Biosafety and Health最新文献

筛选
英文 中文
Review of science and technology innovation policies in major innovative-oriented countries in response to the COVID-19 pandemic 主要创新型国家应对新冠肺炎大流行的科技创新政策回顾
Biosafety and Health Pub Date : 2023-02-01 DOI: 10.1016/j.bsheal.2022.12.001
Tao Yun
{"title":"Review of science and technology innovation policies in major innovative-oriented countries in response to the COVID-19 pandemic","authors":"Tao Yun","doi":"10.1016/j.bsheal.2022.12.001","DOIUrl":"10.1016/j.bsheal.2022.12.001","url":null,"abstract":"<div><p>Since the coronavirus disease 2019 (COVID-19) pandemic, major innovative-oriented countries have adopted various science and technology innovation (STI) policies to address global public health challenges. Using data from the Organization for Economic Co-operation and Development STI Database, this study analyzed international STI policies in response to the COVID-19 pandemic. The findings revealed that the pandemic has dramatically stimulated the application of STI policies, and there are commonalities and differences in the STI policies of different countries. Meanwhile, COVID-19 has disrupted planning for allocating resources for STIs, leading to duplication and inefficiency. Based on the findings, this study recommends increasing research investment to address the long-term challenges of major infectious diseases, strengthening support for enterprises, promoting data sharing and openness, enhancing the internationalization of scientific research, strengthening scientific consultation and communication, and devoting more policy attention to vulnerable groups.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"5 1","pages":"Pages 8-13"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10826565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The prevalence and distribution of aminoglycoside resistance genes 氨基糖苷类耐药基因的流行与分布
Biosafety and Health Pub Date : 2023-02-01 DOI: 10.1016/j.bsheal.2023.01.001
Yuan Zhang , Ning Zhang , Mengyu Wang , Ming Luo , Yao Peng , Zhenpeng Li , Jialiang Xu , Meiling Ou , Biao Kan , Xu Li , Xin Lu
{"title":"The prevalence and distribution of aminoglycoside resistance genes","authors":"Yuan Zhang ,&nbsp;Ning Zhang ,&nbsp;Mengyu Wang ,&nbsp;Ming Luo ,&nbsp;Yao Peng ,&nbsp;Zhenpeng Li ,&nbsp;Jialiang Xu ,&nbsp;Meiling Ou ,&nbsp;Biao Kan ,&nbsp;Xu Li ,&nbsp;Xin Lu","doi":"10.1016/j.bsheal.2023.01.001","DOIUrl":"10.1016/j.bsheal.2023.01.001","url":null,"abstract":"<div><p>Choosing the appropriate antibiotics to treat bacterial infections has grown more challenging as a result of the emergence of antibiotic-resistant bacteria. Aminoglycosides, as broad-spectrum antibiotics, are increasingly being used clinically; however, for most effective employment of aminoglycosides, a comprehensive understanding of aminoglycoside resistance genes’ prevalence and dissemination is required. Therefore, to better understand the global resistance status of aminoglycoside antibiotics and the prevalence of antibiotic-resistance genes (ARGs) in various bacterial species, this systematic review gathered relevant data from multiple studies. Two primary resistance mechanisms—aminoglycoside enzymatic modification and 16S rRNA methylation—were assessed, and the prevalence of the corresponding ARGs was described. The coexistence of aminoglycoside ARGs with other ARGs was also demonstrated, as was the relationship between aminoglycoside ARGs and resistant phenotypes. The lack of effective therapeutic agents to combat resistant pathogens presents a real threat to public health. The combination of aminoglycosides with other antibiotics may provide a novel treatment strategy.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"5 1","pages":"Pages 14-20"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41780569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Temporal dynamics of SARS-CoV-2 genome mutations that occurred in vivo on an aircraft 飞机上体内发生的SARS-CoV-2基因组突变的时间动态
Biosafety and Health Pub Date : 2023-02-01 DOI: 10.1016/j.bsheal.2022.10.004
Yaqing He , Shengyuan Dang , Wentai Ma , Long Chen , Renli Zhang , Shujiang Mei , Xinyi Wei , Qiuying Lv , Bo Peng , Ying Sun , Dongfeng Kong , Jiancheng Chen , Shimin Li , Xiujuan Tang , Qingju Lu , Can Zhu , Zhigao Chen , Jia Wan , Xuan Zou , Mingkun Li , Jianwei Wang
{"title":"Temporal dynamics of SARS-CoV-2 genome mutations that occurred in vivo on an aircraft","authors":"Yaqing He ,&nbsp;Shengyuan Dang ,&nbsp;Wentai Ma ,&nbsp;Long Chen ,&nbsp;Renli Zhang ,&nbsp;Shujiang Mei ,&nbsp;Xinyi Wei ,&nbsp;Qiuying Lv ,&nbsp;Bo Peng ,&nbsp;Ying Sun ,&nbsp;Dongfeng Kong ,&nbsp;Jiancheng Chen ,&nbsp;Shimin Li ,&nbsp;Xiujuan Tang ,&nbsp;Qingju Lu ,&nbsp;Can Zhu ,&nbsp;Zhigao Chen ,&nbsp;Jia Wan ,&nbsp;Xuan Zou ,&nbsp;Mingkun Li ,&nbsp;Jianwei Wang","doi":"10.1016/j.bsheal.2022.10.004","DOIUrl":"https://doi.org/10.1016/j.bsheal.2022.10.004","url":null,"abstract":"<div><p>We analyzed variations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome during a flight-related cluster outbreak of coronavirus disease 2019 (COVID-19) in Shenzhen, China, to explore the characteristics of SARS-CoV-2 transmission and intra-host single nucleotide variations (iSNVs) in a confined space. Thirty-three patients with COVID-19 were sampled, and 14 were resampled 3–31 days later. All 47 nasopharyngeal swabs were deep-sequenced. iSNVs and similarities in the consensus genome sequence were analyzed. Three SARS-CoV-2 variants of concern, Delta (n = 31), Beta (n = 1), and C.1.2 (n = 1), were detected among the 33 patients. The viral genome sequences from 30 Delta-positive patients had similar SNVs; 14 of these patients provided two successive samples. Overall, the 47 sequenced genomes contained 164 iSNVs. Of the 14 paired (successive) samples, the second samples (T2) contained more iSNVs (median: 3; 95% confidence interval [95% CI]: 2.77–10.22) than did the first samples (T1; median: 2; 95% CI: 1.63–3.74; Wilcoxon test, <em>P</em> = 0.021). 38 iSNVs were detected in T1 samples, and only seven were also detectable in T2 samples. Notably, T2 samples from two of the 14 paired samples had additional mutations than the T1 samples. The iSNVs of the SARS-CoV-2 genome exhibited rapid dynamic changes during a flight-related cluster outbreak event. Intra-host diversity increased gradually with time, and new site mutations occurred <em>in vivo</em> without a population transmission bottleneck. Therefore, we could not determine the generational relationship from the mutation site changes alone.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"5 1","pages":"Pages 62-67"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49732553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms 抗病原微生物感染的免疫有效生物材料增强疫苗
Biosafety and Health Pub Date : 2023-02-01 DOI: 10.1016/j.bsheal.2022.11.002
Qi Wei , Shixian Liu , Xu Huang , Hua Xin , Jianxun Ding
{"title":"Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms","authors":"Qi Wei ,&nbsp;Shixian Liu ,&nbsp;Xu Huang ,&nbsp;Hua Xin ,&nbsp;Jianxun Ding","doi":"10.1016/j.bsheal.2022.11.002","DOIUrl":"10.1016/j.bsheal.2022.11.002","url":null,"abstract":"<div><p>Infectious diseases are severe public health events that threaten global health. Prophylactic vaccines have been considered as the most effective strategy to train the immune system to recognize and clear pathogenic infections. However, the existing vaccines against infectious diseases have several limitations, such as difficulties in mass manufacturing and storage, weak immunogenicity, and low efficiency of available adjuvants. Biomaterials, especially functional polymers, are expected to break through these bottlenecks based on the advantages of biocompatibility, degradability, controlled synthesis, easy modification, precise targeting, and immune modulation, which are excellent carriers and adjuvants of vaccines. This review mainly summarizes the application of immunologically effective polymers-enhanced vaccines against viruses- and bacteria-related infectious diseases and predicted their potential improvements.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"5 1","pages":"Pages 45-61"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45147544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Editorial note to previously published articles 对以前发表的文章的编辑说明
Biosafety and Health Pub Date : 2023-01-01 DOI: 10.1016/j.bsheal.2023.10.004
{"title":"Editorial note to previously published articles","authors":"","doi":"10.1016/j.bsheal.2023.10.004","DOIUrl":"https://doi.org/10.1016/j.bsheal.2023.10.004","url":null,"abstract":"","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"5 6","pages":"Page 372"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590053623001283/pdfft?md5=88c681e8949a397a2072833b683eaa7f&pid=1-s2.0-S2590053623001283-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Internet of things (IoT) imbedded point-of-care SARS-CoV-2 testing in the pandemic and post-pandemic era 在大流行和大流行后时代,物联网(IoT)嵌入式SARS-CoV-2即时检测
Biosafety and Health Pub Date : 2022-12-01 DOI: 10.1016/j.bsheal.2022.09.005
Zhaoxi Wang , Simin Liu
{"title":"Internet of things (IoT) imbedded point-of-care SARS-CoV-2 testing in the pandemic and post-pandemic era","authors":"Zhaoxi Wang ,&nbsp;Simin Liu","doi":"10.1016/j.bsheal.2022.09.005","DOIUrl":"10.1016/j.bsheal.2022.09.005","url":null,"abstract":"<div><p>The outbreaks of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant in China have revealed a high rate of asymptomatic cases, making isolation and quarantine measures exceedingly difficult. Public health surveillance and intervention measures will require rapid and accurate testing preferably on-site using point-of-care tests (POCTs) technology for SARS-CoV-2 variants. However, delayed and/or inaccurate surveillance data is a major obstacle blocking the large-scale implementation of POCTs in curbing spread of infectious pathogens and reducing mortality during an outbreak. To determine levels of community transmission and timely strategies accordingly, highly sensitive and specific POCT embedded with the internet of things (IoT) technology could enable on-site screening and real-time data collection. A new Rapid Amplification with Sensitivity And Portability point-of-care test (RASAP-POCT) system based on thermal convection PCR is the first IoT-based isothermal nucleic acid amplification POCT, which can provide test results within 20–30 min using saliva and/or nasopharyngeal swab samples without nucleic acid extraction. With the IoT-imbedded feature, the RASAP-POCT system can be integrated easily and smoothly with China’s existing mobile-phone-based contact tracing system, which has previously proved to be highly effective in maintaining the dynamic zero-COVID policy. Current regulatory guidelines and rules should be modified to accelerate the adoption of new technologies under an emergency use authorization (EUA).</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"4 6","pages":"Pages 365-368"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502434/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10770761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Access and benefit-sharing of the pathogenic microorganisms such as SARS-CoV-2 SARS-CoV-2等病原微生物的获取和惠益分享
Biosafety and Health Pub Date : 2022-12-01 DOI: 10.1016/j.bsheal.2022.05.003
Yalin Zhai , Geng Hong , Mengnan Jiang , Qiang Wei
{"title":"Access and benefit-sharing of the pathogenic microorganisms such as SARS-CoV-2","authors":"Yalin Zhai ,&nbsp;Geng Hong ,&nbsp;Mengnan Jiang ,&nbsp;Qiang Wei","doi":"10.1016/j.bsheal.2022.05.003","DOIUrl":"10.1016/j.bsheal.2022.05.003","url":null,"abstract":"<div><p>With the outbreak of coronavirus disease 2019 (COVID-19), it is essential to share pathogens and their data information safely, transparently, and timely. At the same time, it is also worth exploring how to share the benefits of using the provided pathogenic microorganisms fairly and equitably. There are some mechanisms for the management and sharing of pathogenic microbial resources in the world, such as the World Health Organization (WHO), the United States, the Europe, and China. This paper studies these mechanisms and puts forward “PICC” principles, including public welfare principle, interests principle, classified principle, and category principle, to strengthen cooperation, improve efficiency, and maintain biosafety.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"4 6","pages":"Pages 414-420"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9224218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating research infrastructures into infectious diseases surveillance operations: Focus on biobanks 将研究基础设施纳入传染病监测行动:重点放在生物库上
Biosafety and Health Pub Date : 2022-12-01 DOI: 10.1016/j.bsheal.2022.10.001
Plebeian B. Medina , Jennifer Kealy , Zisis Kozlakidis
{"title":"Integrating research infrastructures into infectious diseases surveillance operations: Focus on biobanks","authors":"Plebeian B. Medina ,&nbsp;Jennifer Kealy ,&nbsp;Zisis Kozlakidis","doi":"10.1016/j.bsheal.2022.10.001","DOIUrl":"10.1016/j.bsheal.2022.10.001","url":null,"abstract":"<div><p>Technological advances in the first two decades of the 21<sup>st</sup> century have profoundly impacted medical research in many ways, with large population cohorts, biological sample collections and datasets through biobanks becoming valued global resources to guide biomedical research, drug development, and medical practice. However, in order for biobanks to maximize their impact and scientific reach of their resources, they would need to act within a complex network of infrastructures and activities. Therefore, different ways have emerged in which biobanks, including those for infectious diseases, can emerge as (part of) infrastructures, integrate within existing ones, or become an independent, yet an interoperable component of the existing infrastructural landscape. However, there has been a limited understanding and study of such mechanisms to date. This perspective aims to address this knowledge gap and illustrates these three high-level ways in which such infrastructures could integrate their activities and identifies the necessary key pre-conditions for doing so, while drawing from specific examples.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"4 6","pages":"Pages 410-413"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10750779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological characteristics, biosafety prevention and control strategies for the 2022 multi-country outbreak of monkeypox 2022年猴痘多国暴发的生物学特征及生物安全防控策略
Biosafety and Health Pub Date : 2022-12-01 DOI: 10.1016/j.bsheal.2022.11.001
Chudan Liang , Jun Qian , Linna Liu
{"title":"Biological characteristics, biosafety prevention and control strategies for the 2022 multi-country outbreak of monkeypox","authors":"Chudan Liang ,&nbsp;Jun Qian ,&nbsp;Linna Liu","doi":"10.1016/j.bsheal.2022.11.001","DOIUrl":"10.1016/j.bsheal.2022.11.001","url":null,"abstract":"<div><p>Monkeypox is a zoonotic disease caused by the monkeypox virus (MPXV), which is a potential biological warfare agent of bioterrorism and poses the greatest threat to the world’s public biosafety and health after variola virus (VARV). While the coronavirus disease 2019 (COVID-19) pandemic has not ended yet, monkeypox is spreading menacingly. The first case of monkeypox in a nonendemic country was confirmed on May 6<sup>th</sup>, 2022, while the first imported case from Asia was found on June 21<sup>st</sup>. There were more than 16 thousand reported cases as of July 23<sup>rd</sup>, the day the World Health Organization (WHO) declared the global monkeypox outbreak a public health emergency of international concern (PHEIC) at the same level as smallpox and COVID-19; while there were more than 53 thousand cases as of September 1<sup>st</sup>. Therefore, we will propose relevant biosafety prevention and control strategies after analyzing the etiology of the 2022 multi-country monkeypox outbreak from the biological feature, transmissibility, epidemic, and variability of MPXV.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"4 6","pages":"Pages 376-385"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9183412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Genome editing and human rights: Implications of the UNGPs 基因组编辑与人权:ungp的影响
Biosafety and Health Pub Date : 2022-12-01 DOI: 10.1016/j.bsheal.2022.10.002
Leifan Wang , Xiaohui Liang , Weiwen Zhang
{"title":"Genome editing and human rights: Implications of the UNGPs","authors":"Leifan Wang ,&nbsp;Xiaohui Liang ,&nbsp;Weiwen Zhang","doi":"10.1016/j.bsheal.2022.10.002","DOIUrl":"10.1016/j.bsheal.2022.10.002","url":null,"abstract":"<div><p>How to address the impact of genome editing on human rights is a global challenge. The World Health Organization (WHO) recently developed a governance framework for human genome editing to provide global recommendations for establishing appropriate governance mechanisms for human genome editing. This article suggests that a human rights-respecting approach should be explicitly recognized in the framework and other relevant endeavors. Such recognition has significant implications not only on clarifying the duty of States but also on the responsibility of non-State actors, particularly biotech enterprises, to orient this technology towards respect for human rights. To implement this approach, <em>the United Nations Guiding Principles on Business and Human Rights</em> (UNGPs) provide helpful guidance for States, biotech enterprises, and other stakeholders to raise awareness and enhance responsible practices in the field.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"4 6","pages":"Pages 386-391"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590053622001537/pdfft?md5=b0acec9b7583f1fa84ae18efccb8e61e&pid=1-s2.0-S2590053622001537-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41946329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信